Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calzetta

Showing results (91-100 of 459) with videos related to

Pageof 46
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|June 2, 2025
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-AnalysisPaola Rogliani, Gian Marco Manzetti, Mario Cazzola, et al.
Expert Opinion on Drug Safety|June 10, 2016
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysisPaola Rogliani, Luigino Calzetta, Mario Cazzola, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2017
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthmaMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 11, 2017
Pharmacogenetic and pharmacogenomic considerations of asthma treatmentMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Molecular Diagnosis & Therapy|March 2, 2017
The Challenges of Precision Medicine in COPDMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Opinion on Emerging Drugs|February 17, 2012
Emerging drugs for chronic obstructive pulmonary diseaseMaria Gabriella Matera, Luigino Calzetta, Andrea Segreti, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 23, 2017
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthmaMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Expert Opinion on Investigational Drugs|September 3, 2019
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPDMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Review of Respiratory Medicine|July 5, 2018
Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary diseaseLuigino Calzetta, Maria Gabriella Matera, Paola Rogliani, et al.
Drugs|October 11, 2014
Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold?Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Pageof 46

Showing results (91-100 of 459) with videos related to

Sort By:
Pageof 46
International Journal of Chronic Obstructive Pulmonary Disease|June 2, 2025
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-AnalysisPaola Rogliani, Gian Marco Manzetti, Mario Cazzola, et al.
Expert Opinion on Drug Safety|June 10, 2016
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysisPaola Rogliani, Luigino Calzetta, Mario Cazzola, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2017
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthmaMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 11, 2017
Pharmacogenetic and pharmacogenomic considerations of asthma treatmentMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Molecular Diagnosis & Therapy|March 2, 2017
The Challenges of Precision Medicine in COPDMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Opinion on Emerging Drugs|February 17, 2012
Emerging drugs for chronic obstructive pulmonary diseaseMaria Gabriella Matera, Luigino Calzetta, Andrea Segreti, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 23, 2017
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthmaMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Expert Opinion on Investigational Drugs|September 3, 2019
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPDMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Review of Respiratory Medicine|July 5, 2018
Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary diseaseLuigino Calzetta, Maria Gabriella Matera, Paola Rogliani, et al.
Drugs|October 11, 2014
Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold?Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Pageof 46